Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New CDK9/cyclin T1 inhibitors identified at Algen Biotechnologies

Dec. 9, 2021

Shanghai Meiyue Biotech Development describes new coagulation factor XIa inhibitors

Dec. 9, 2021

Incyte describes new mutant GTPase KRAS inhibitors

Dec. 7, 2021

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Dec. 7, 2021

New ACSS2 inhibitors discovered at Metabomed

Dec. 7, 2021

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

Dec. 7, 2021

Jiangsu Protelight Pharmaceutical & Biotechnology patents amino acid derivatives

Dec. 7, 2021

J2H Biotech synthesizes new compounds for liver cancer

Dec. 3, 2021

Bristol Myers Squibb synthesizes new galectin-3 inhibitors

Dec. 3, 2021

PMV Pharmaceuticals identifies new TP53 mutant stabilizers

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...